Valsartan improved myocardial fibrosis and diastolic dysfunction in hypertensive patients, preferentially in patients with severe fibrosis

被引：0
|
作者：
Mizuta, Yoshihiko [1 ]
Kai, Hisashi [1 ]
Mizoguchi, Minori [1 ]
Tahara, Nobuhiro [1 ]
Osada, Katsunori [1 ]
Imaizumi, Tsutomu [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
来源：
HYPERTENSION | 2008年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E78 / E78
页数：1
相关论文
共 50 条
  • [1] Long-term treatment with valsartan attenuates myocardial fibrosis and improves diastolic dysfunction in hypertensive patients - The echorcardiographic assessment
    Mizuta, Yoshihiko
    Kai, Hisashi
    Fukui, Minori
    Imaizumi, Tsutomu
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : S150 - S150
  • [2] Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis
    Losi, Maria Angela
    Memoli, Bruno
    Contaldi, Carla
    Barbati, Giovanni
    Del Prete, Marco
    Betocchi, Sandro
    Cavallaro, Massimo
    Carpinella, Gerardo
    Fundaliotis, Angelica
    Parrella, Lucia-S
    Parisi, Valentina
    Guida, Bruna
    Chiariello, Massimo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (06) : 1950 - 1954
  • [3] FIBROSIS AS STRUCTURAL BASIS OF DIASTOLIC DYSFUNCTION IN THE ELDERLY HYPERTENSIVE PATIENTS
    TJAHJA, IE
    AGGARWAL, K
    BROWER, C
    MCLAUGHLIN, P
    CAMPBELL, SE
    WEBER, KT
    CLINICAL RESEARCH, 1994, 42 (03): : A365 - A365
  • [4] Hypertensive myocardial fibrosis and Diastolic dysfunction - Another model of inflammation?
    Kuwahara, F
    Kai, H
    Tokuda, K
    Takeya, M
    Takeshita, A
    Egashira, K
    Imaizumi, T
    HYPERTENSION, 2004, 43 (04) : 739 - 745
  • [5] Valsartan attenuated myocardial fibrosis and diastolic dysfunction of hypertensive hearts in humans. Assessments using integrated backscatter analysis
    Mizuta, Y.
    Kai, H.
    Mizoguchi, M.
    Imaizumi, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 48 - 48
  • [6] Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
    Liu, Dan
    Oder, Daniel
    Salinger, Tim
    Hu, Kai
    Muentze, Jonas
    Weidemann, Frank
    Herrmann, Sebastian
    Ertl, Georg
    Wanner, Christoph
    Frantz, Stefan
    Stoerk, Stefan
    Nordbeck, Peter
    OPEN HEART, 2018, 5 (02):
  • [7] Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis
    Hisashi Kai
    Fumitaka Kuwahara
    Keisuke Tokuda
    Tsutomu Imaizumi
    Hypertension Research, 2005, 28 : 483 - 490
  • [8] Diastolic dysfunction in hypertensive hearts: Roles of perivascular inflammation and reactive myocardial fibrosis
    Kai, H
    Kuwahara, F
    Tokuda, K
    Imaizumi, T
    HYPERTENSION RESEARCH, 2005, 28 (06) : 483 - 490
  • [9] Myocardial Fibrosis and Diastolic Dysfunction Following Calcium-Channel Blockers or Angiotensin II Receptor Blockers in Hypertensive Patients
    Yoshida, Chikako
    Tsujino, Takeshi
    Goda, Akiko
    Matsumoto, Mika
    Naito, Yoshiro
    Nakao, Shinji
    Ezumi, Akira
    Lee-Kawabata, Masaaki
    Masuyama, Tohru
    CIRCULATION, 2008, 118 (18) : S957 - S957
  • [10] Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats
    Matsubara, LS
    Matsubara, BB
    Okoshi, MP
    Franco, M
    Cicogna, AC
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (12) : 1328 - 1334
12345